ALBEGA Medical Company Profile
ALBEGA Medical, founded in 2019 and headquartered in Berlin, Germany, is a private startup specializing in developing novel radiopharmaceuticals for oncology treatments, particularly brain tumors and glioma, and recently secured a $5.69 million grant from government investors including the European Union and Horizon 2020.
Overview
- Year Founded: 2019
- Status: Private
- Latest Deal Type: Grant
- Latest Deal Amount: $5.69M
- Investors: 2
General Information
ALBEGA Medical is a developer of novel radiopharmaceuticals intended for oncology treatments. The company's radiopharmaceuticals utilize radio-ligand diagnostics and therapeutics for the treatment of brain tumors and glioma therapeutics, enabling healthcare professionals to treat cancer patients.
Contact Information
-
Website: www.albega-medical.com
-
Corporate Office:
- Morgensternstraße 24
- 12207 Berlin
- Germany
- +49 030
-
Primary Industry: Drug Discovery
-
Verticals: Life Sciences, Oncology
Valuation & Funding
- Deal Type: Grant
- Amount: $5.69M
- Status: Completed
- Stage: Startup
Investors
- European Union (Government)
- Horizon 2020 (Government)
FAQs
When was ALBEGA Medical founded?
ALBEGA Medical was founded in 2019.
Where is ALBEGA Medical headquartered?
ALBEGA Medical is headquartered in Berlin, Germany.
What industry is ALBEGA Medical in?
ALBEGA Medical’s primary industry is Drug Discovery.
Is ALBEGA Medical a private or public company?
ALBEGA Medical is a private company.
Who are ALBEGA Medical’s investors?
European Union and Horizon 2020 have invested in ALBEGA Medical.